What does CUSIP 007002108 represent in this 13F holders report?

CUSIP 007002108 is the security identifier for ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 used to aggregate holder disclosures.

How many institutions held ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in Q4 2022?

100 institutional investors reported ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 for Q4 2022. Use the holders table for investor-level position and value details.

Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

CUSIP: 007002108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, par value $0.0001
Shares outstanding: 9,599,852
Total 13F shares: 42,143,638
Share change: +591,010
Total reported value: $376,757,638
Put/Call ratio: 83%
Price per share: $8.94
Number of holders: 100
Value change: -$18,208,642
Number of buys: 52
Number of sells: 52

Quarterly Holders Quick Answers

What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 007002108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	78%	7,447,140	$105,898,000	—	30 Sep 2022	13F
RTW INVESTMENTS, LP	13F	Company	44%	4,241,472	$60,314,000	—	30 Sep 2022	13F
COWEN AND COMPANY, LLC	13F	Company	25%	2,443,246	$34,743,000	—	30 Sep 2022	13F
Abingworth LLP	13F	Company	22%	2,115,385	$30,017,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	22%	2,109,787	$30,003,000	—	30 Sep 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	21%	2,059,372	$29,284,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	20%	1,958,265	$27,847,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	17%	1,660,667	$23,616,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	16%	1,499,259	$21,319,000	—	30 Sep 2022	13F
S.c.a. Candriam	13F	Individual	15%	1,452,109	$20,650,000	—	30 Sep 2022	13F
Cormorant Asset Management, LP	13F	Company	15%	1,400,000	$19,908,000	—	30 Sep 2022	13F
Polar Capital Holdings Plc	13F	Company	13%	1,293,670	$18,396,000	—	30 Sep 2022	13F
DAFNA Capital Management LLC	13F	Company	9.7%	935,766	$13,307,000	—	30 Sep 2022	13F
Deep Track Capital, LP	13F	Company	8.6%	825,508	$11,739,000	—	30 Sep 2022	13F
FMR LLC	13F	Company	8.4%	809,351	$11,509,000	—	30 Sep 2022	13F
JOHNSON & JOHNSON	13F	Company	7.6%	728,944	$10,366,000	—	30 Sep 2022	13F
Foresite Capital Management V, LLC	13F	Company	7.1%	680,000	$9,670,000	—	30 Sep 2022	13F
DEUTSCHE BANK AG\	13F	Company	7%	675,976	$9,612,000	—	30 Sep 2022	13F
Decheng Capital Management III (Cayman), LLC	13F	Company	6%	580,000	$8,248,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	5.6%	538,495	$7,657,000	—	30 Sep 2022	13F
Sofinnova Investments, Inc.	13F	Company	5.1%	491,965	$6,996,000	—	30 Sep 2022	13F
Assenagon Asset Management S.A.	13F	Company	4.4%	417,863	$5,942,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	4.1%	395,081	$5,618,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	4.1%	389,926	$5,545,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	2.7%	261,527	$3,719,000	—	30 Sep 2022	13F
Ally Bridge Group (NY) LLC	13F	Company	2.5%	244,400	$3,475,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	2.5%	240,997	$3,427,000	—	30 Sep 2022	13F
JANE STREET GROUP, LLC	13F	Company	2.2%	212,404	$3,020,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	2.2%	210,696	$2,996,000	—	30 Sep 2022	13F
BAILLIE GIFFORD & CO	13F	Company	1.9%	181,626	$2,583,000	—	30 Sep 2022	13F
Foresite Capital Opportunity Management V, LLC	13F	Company	1.8%	170,000	$2,417,000	—	30 Sep 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	1.6%	154,708	$2,195,000	—	30 Sep 2022	13F
Altium Capital Management LLC	13F	Company	1.6%	150,000	$2,133,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	1.4%	134,491	$1,913,000	—	30 Sep 2022	13F
Rafferty Asset Management, LLC	13F	Company	1.4%	131,509	$1,870,000	—	30 Sep 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	1.3%	124,379	$1,769,000	—	30 Sep 2022	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	1.3%	121,471	$1,727,318	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.3%	120,782	$1,718,000	—	30 Sep 2022	13F
CITIGROUP INC	13F	Company	1.3%	120,107	$1,708,000	—	30 Sep 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.2%	113,834	$1,619,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	1.2%	112,853	$1,605,000	—	30 Sep 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	1.2%	112,355	$1,598,000	—	30 Sep 2022	13F
Ensign Peak Advisors, Inc	13F	Company	1.1%	109,389	$1,556,000	—	30 Sep 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.99%	95,089	$1,350,000	—	30 Sep 2022	13F
Laurion Capital Management LP	13F	Company	0.95%	90,849	$1,292,000	—	30 Sep 2022	13F
MARSHALL WACE, LLP	13F	Company	0.88%	84,548	$1,202,000	—	30 Sep 2022	13F
BARCLAYS PLC	13F	Company	0.86%	82,407	$1,172,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.78%	75,316	$1,071,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.67%	64,000	$910,000	—	30 Sep 2022	13F
J. Goldman & Co LP	13F	Company	0.59%	57,094	$812,000	—	30 Sep 2022	13F

Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2022

As of 31 Dec 2022, Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,143,638 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, EcoR1 Capital, LLC, COWEN AND COMPANY, LLC, BlackRock Inc., STATE STREET CORP, Abingworth LLP, VANGUARD GROUP INC, MORGAN STANLEY, and Polar Capital Holdings Plc. This page lists 100 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

100

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.